Interactive Financial Charts Not Available

Concentra (CON) | Financial Analysis & Statements

Concentra Group Holdings Inc. | Mid-cap | Healthcare

$20.40

0.99%

Concentra vs HCA Healthcare Concentra vs Tenet Healthcare Concentra vs Ensign Group Concentra vs Chemed Concentra vs Option Care Health Concentra vs S&P 500 | Market

TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Mar 2025

Income Metrics

Revenue 500.8M

Gross Profit 143.7M 28.69%

Operating Income 80.3M 16.04%

Net Income 40.6M 8.12%

EPS (Diluted) $0.30

Balance Sheet Metrics

Total Assets 2.7B

Total Liabilities 2.4B

Shareholders Equity 331.1M

Debt to Equity 7.24

Cash Flow Metrics

Operating Cash Flow 36.5M

Free Cash Flow -4.0M

Revenue & Profitability Trend

Interactive Financial Charts Not Available

This page uses interactive financial charts and dynamic data visualization tools that require JavaScript. For detailed financial analysis:

Available Financial Data:

Income statements (annual and quarterly)
Balance sheets with asset and liability details
Cash flow statements and free cash flow analysis
Key financial ratios and performance metrics
Peer comparison and industry benchmarking

All financial data is displayed in accessible table format below. Use the table headers and structure to analyze trends and compare metrics across different periods.

Concentra Income Statement From 2021 to 2024

Metric	2024	2023	2022	2021
Revenue i	1.9B	1.8B	1.7B	1.7B
Cost of Goods Sold i	1.4B	1.3B	1.2B	1.2B
Gross Profit i	528.0M	512.4M	481.9M	510.2M
Gross Margin % i	27.8%	27.9%	27.9%	29.5%
Operating Expenses
Research & Development i	-	-	-	-
Selling, General & Administrative i	156.3M	152.4M	150.0M	157.7M
Other Operating Expenses i	-284.0K	-250.0K	-312.0K	-35.0M
Total Operating Expenses i	156.0M	152.1M	149.7M	122.7M
Operating Income i	304.8M	287.3M	258.5M	305.3M
Operating Margin % i	16.0%	15.6%	15.0%	17.6%
Non-Operating Items
Interest Income i	-	-	-	-
Interest Expense i	69.7M	114.0M	31.6M	31.9M
Other Non-Operating Income	-3.7M	-528.0K	-2.0M	2.2M
Pre-tax Income i	231.4M	172.7M	224.9M	275.6M
Income Tax i	59.5M	40.3M	52.7M	59.5M
Effective Tax Rate % i	25.7%	23.3%	23.4%	21.6%
Net Income i	171.9M	132.4M	172.2M	216.0M
Net Margin % i	9.0%	7.2%	10.0%	12.5%
Key Metrics
EBITDA i	368.3M	359.8M	330.2M	387.5M
EPS (Basic) i	$1.46	$1.01	$1.32	$1.65
EPS (Diluted) i	$1.46	$1.01	$1.32	$1.65
Basic Shares Outstanding i	114070548	126691216	126593503	126593503
Diluted Shares Outstanding i	114070548	126691216	126593503	126593503

Income Statement Trend

Concentra Balance Sheet From 2022 to 2024

Metric	2024	2023	2022
Assets
Current Assets
Cash & Equivalents i	183.3M	31.4M	37.7M
Short-term Investments i	-	-	-
Accounts Receivable i	217.7M	216.2M	206.3M
Inventory i	-	-	-
Other Current Assets	34.7M	38.9M	34.0M
Total Current Assets i	437.2M	294.4M	284.6M
Non-Current Assets
Property, Plant & Equipment i	435.6M	397.9M	375.1M
Goodwill i	2.7B	2.7B	2.7B
Intangible Assets i	204.7M	224.8M	247.6M
Long-term Investments	-	-	-
Other Non-Current Assets	11.0M	8.4M	5.2M
Total Non-Current Assets i	2.1B	2.0B	2.0B
Total Assets i	2.5B	2.3B	2.3B
Liabilities
Current Liabilities
Accounts Payable i	19.8M	20.4M	27.7M
Short-term Debt i	85.5M	74.4M	73.0M
Current Portion of Long-term Debt	-	-	-
Other Current Liabilities	-	-	-
Total Current Liabilities i	307.2M	274.6M	279.6M
Non-Current Liabilities
Long-term Debt i	1.9B	830.6M	966.7M
Deferred Tax Liabilities i	25.4M	23.4M	29.8M
Other Non-Current Liabilities	24.0M	27.5M	25.0M
Total Non-Current Liabilities i	1.9B	881.5M	1.0B
Total Liabilities i	2.2B	1.2B	1.3B
Equity
Common Stock i	-	-	-
Retained Earnings i	13.6M	685.3M	508.6M
Treasury Stock i	-	-	-
Other Equity	-	-	-
Total Shareholders Equity i	298.7M	1.2B	996.1M
Key Metrics
Total Debt i	2.0B	905.0M	1.0B
Working Capital i	130.0M	19.8M	5.0M

Balance Sheet Composition

Concentra Cash Flow Statement From 2021 to 2024

Metric	2024	2023	2022	2021
Operating Activities
Net Income i	171.9M	184.7M	172.2M	216.0M
Depreciation & Amortization i	67.2M	73.1M	73.7M	82.2M
Stock-Based Compensation i	2.3M	651.0K	2.1M	2.1M
Working Capital Changes i	5.6M	-28.3M	115.0K	11.9M
Operating Cash Flow i	246.4M	223.9M	239.8M	312.1M
Investing Activities
Capital Expenditures i	-64.3M	-65.0M	-46.0M	-46.8M
Acquisitions i	-7.0M	-6.0M	-11.8M	-20.1M
Investment Purchases i	-	-	-	-
Investment Sales i	-	-	-	-
Investing Cash Flow i	-71.3M	-70.9M	-57.8M	-61.8M
Financing Activities
Share Repurchases i	-15.4M	0	-23.9M	0
Dividends Paid i	-1.5B	-	-	-
Debt Issuance i	1.5B	5.5M	4.3M	0
Debt Repayment i	-492.3M	-167.2M	-188.9M	-326.9M
Financing Cash Flow i	-51.5M	-168.6M	-213.2M	-352.7M
Free Cash Flow i	210.4M	165.0M	228.4M	243.9M
Net Change in Cash i	123.6M	-15.7M	-31.1M	-102.4M

Cash Flow Trend

Concentra Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 14.92

Forward P/E 16.35

Price to Book 8.53

Price to Sales 1.36

PEG Ratio 16.35

Profitability Ratios

Profit Margin 8.10%

Operating Margin 16.73%

Return on Equity 20.93%

Return on Assets 7.69%

Financial Health

Current Ratio 1.10

Debt to Equity 645.86

Per Share Data

EPS (TTM) $1.37

Book Value per Share $2.40

Revenue per Share $16.15

Peer Financial Comparison

Company	Market Cap	P/E Ratio	P/B Ratio	ROE	Profit Margin	Debt/Equity
con	2.6B	14.92	8.53	20.93%	8.10%	645.86
HCA Healthcare	82.9B	14.47	-194.42	13,631.68%	8.21%	-105.85
Tenet Healthcare	14.9B	10.12	3.91	29.65%	7.18%	158.70
Ensign Group	8.5B	26.77	4.19	17.54%	7.00%	100.93
Chemed	6.9B	22.94	5.75	26.11%	12.40%	12.28
Option Care Health	4.9B	24.10	3.65	15.38%	4.12%	90.53

Financial data is updated regularly. All figures are in the company's reporting currency.